Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Integration Plan being discussed at HQ
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4387979"]The buyer of Amylin wants to keep the Amylin sales force. They recognize that Novo is beefing up it's sales force and wants to be able to have the manpower to counter detail. </p><p><br /></p><p>The "new" owner does not see the value in continuing the contract with InVentiv Synergy contract and definitely does not see the value in continuing the Specialty/Symlin InVentiv contract. </p><p><br /></p><p>The new company plans to have their sales force fully "integrated" with the Amylin sales force by late spring of 2012 to launch the Bydureon pen. This will give the "new" owner of Amylin time to develop and realign their management team. Having regional and district managers from the "new" company overseeing the Amylin sales force will help facilitate a more fluid transition and give more uniformity to the whole sales force.</p><p><br /></p><p>This integration plan is what pushed Amyin to announce the retention plan. Even though the "new" owner is only interested in keeping the Amlin sales force and not the Inventive sales force or and Amylin middle management.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4387979"]The buyer of Amylin wants to keep the Amylin sales force. They recognize that Novo is beefing up it's sales force and wants to be able to have the manpower to counter detail. The "new" owner does not see the value in continuing the contract with InVentiv Synergy contract and definitely does not see the value in continuing the Specialty/Symlin InVentiv contract. The new company plans to have their sales force fully "integrated" with the Amylin sales force by late spring of 2012 to launch the Bydureon pen. This will give the "new" owner of Amylin time to develop and realign their management team. Having regional and district managers from the "new" company overseeing the Amylin sales force will help facilitate a more fluid transition and give more uniformity to the whole sales force. This integration plan is what pushed Amyin to announce the retention plan. Even though the "new" owner is only interested in keeping the Amlin sales force and not the Inventive sales force or and Amylin middle management.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Integration Plan being discussed at HQ
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Integration Plan being discussed at HQ
>